Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis B vaccination in preterm infants

F Y Huang1, P I Lee, C Y Lee

  • 1Department of Paediatrics, Mackay Memorial Hospital, Taipei, Taiwan.

Archives of Disease in Childhood. Fetal and Neonatal Edition
|February 12, 1998
PubMed
Summary

Hepatitis B vaccination is safe and effective for preterm infants. Two different vaccination schedules showed similar immunogenicity, supporting current recommendations for premature babies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of hyperthermia on intracellular pH in human U-87 MG glioblastoma cells.

Oncology·1995
Same author

Purified rat acid-labile subunit and recombinant human insulin-like growth factor (IGF)-binding protein-3 can form a 150-kilodalton binary complex in vitro in the absence of IGFs.

Endocrinology·1995
Same author

Molecular analysis of an extracellular protease gene from Vibrio parahaemolyticus.

Microbiology (Reading, England)·1995
Same author

Set-shifting aptitude in Parkinson's disease: external versus internal cues.

Psychological reports·1995
Same author

Luminal epidermal growth factor is trophic to the small intestine of parenterally fed rats.

Clinical science (London, England : 1979)·1995
Same author

Comparative mathematical analyses of freezing in lung and solid tissue.

Cryobiology·1995

Area of Science:

  • Immunology
  • Pediatrics
  • Vaccinology

Background:

  • Hepatitis B remains a significant global health concern.
  • Preterm infants may have altered immune responses to vaccinations.
  • Evaluating vaccine schedules in vulnerable populations is crucial.

Purpose of the Study:

  • To assess the immunogenicity and safety of hepatitis B vaccination in preterm infants.
  • To compare two different vaccination schedules for preterm infants.
  • To determine if current recommendations are effective for premature babies.

Main Methods:

  • 85 preterm infants received recombinant hepatitis B vaccine (5 micrograms/dose).
  • Group A (<2000 g birthweight) received doses at 1, 2, and 7 months.
  • Group B (>=2000 g birthweight) received doses at 0, 1, and 6 months.

Related Experiment Videos

Main Results:

  • Protective antibody levels were achieved in 95% of Group A and 90% of Group B.
  • No significant difference in seropositive rates or antibody concentrations between groups.
  • Immune response in preterm infants was comparable to term infants.

Conclusions:

  • Preterm infants can be effectively vaccinated against hepatitis B using two distinct schedules.
  • A birthweight cutoff of 2000 g can guide vaccination timing.
  • Current hepatitis B vaccination strategies are suitable for preterm infants.